Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
Clinical trial NCT04561206 · RECRUITING
Trial details
- NCT number
- NCT04561206
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2026-10-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.